Home / Online GXP courses / Pharmaceuticals / Anti-Money Laundering Compliance in Life Sciences
Successful completion provides learners with a dated, traceable and downloadable certificate for the course :
Each certificate is CPD/CEU accredited and 21 CFR PART 11 compliant. Certificates validity can be checked online through our certificate online checker. They can also be shared on Linkedin.
The life sciences industry operates within complex global supply chains and high-value transactions, making it vulnerable to money-laundering and financial-crime risks. Pharmaceutical, biotech, medical-device, and clinical research organizations must understand how Anti-Money Laundering (AML) requirements apply to their operations.
This course provides a practical overview of AML compliance in the life sciences industry. Learners will explore how global AML frameworks apply across the U.S., EU, and UK, and how effective AML programs are built and maintained.
By completing this course, you will gain the knowledge needed to identify AML risks, understand due-diligence and reporting expectations, and support compliant, ethical operations within regulated life-sciences environments.
Upon successful completion, you will receive a validated certificate accredited with CPD/CEU credits, suitable for audit and compliance documentation.
✅ Who should enroll?
🎯 What you’ll learn?
Lesson 1: Money Laundering and Its Relevance to Life Sciences
Lesson 2: Global and Regional AML Frameworks (FATF, EU, UK, U.S.)
Lesson 3: Customer Due Diligence (CDD), Enhanced Due Diligence (EDD), and Beneficial Ownership
Lesson 4: Payments, Sanctions, and Red Flags in Life-Sciences Transactions
Lesson 5: Building an AML Compliance Program for Life-Sciences Organizations
Lesson 6: Investigations, Reporting, and Regulatory Interaction
Conclusion
Assessment
$95,00 / year
$95,00 / year